SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2020 • Cardiff Oncology, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledMay 19th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is entered into as of May 14, 2020 (the “Effective Date”), by and between Cardiff Oncology, Inc., a Delaware corporation (the “Company”), and the subscriber identified on the signature pages hereto (the “Subscriber”).